市場調查報告書

梅毒免疫測量診斷市場(各產品:各分析設備,套件·試劑,技術:EISA,CLIA,其他,各終端用戶:醫院,診斷測試所,血庫,其他):全球產業分析,規模,佔有率,成長,趨勢,預測(2019∼2027年)

Syphilis Immunoassay Diagnostics Market (Product: Analyzers, Kits & Reagents; Technology: ELISA, CLIA, Others; End User: Hospitals, Diagnostic Labs, Blood Banks, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 920611
出版日期 內容資訊 英文 207 Pages
商品交期: 最快1-2個工作天內
價格
梅毒免疫測量診斷市場(各產品:各分析設備,套件·試劑,技術:EISA,CLIA,其他,各終端用戶:醫院,診斷測試所,血庫,其他):全球產業分析,規模,佔有率,成長,趨勢,預測(2019∼2027年) Syphilis Immunoassay Diagnostics Market (Product: Analyzers, Kits & Reagents; Technology: ELISA, CLIA, Others; End User: Hospitals, Diagnostic Labs, Blood Banks, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2019年12月03日內容資訊: 英文 207 Pages
簡介

本報告提供梅毒免疫測量診斷市場相關調查,彙整市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場分析與預測

第5章 市場預測

  • 技術進步
  • 主要的合併·收購
  • 大3公司分析
  • 梅毒診斷測試數
  • 價格分析
  • 罹患率與發病率

第6章 市場分析與預測:各產品

  • 簡介和定義
  • 主要調查結果/趨勢
  • 市場價值預測
    • 分析設備
    • 套件·試劑
  • 市場魅力度

第7章 市場分析與預測:各技術

  • 簡介和定義
  • 主要調查結果/趨勢
  • 市場價值預測
    • ELISA
    • CLIA
    • 其他
  • 市場魅力度

第8章 市場分析與預測:各終端用戶

  • 簡介和定義
  • 主要調查結果/趨勢
  • 市場價值預測
    • 醫院
    • 診斷測試所
    • 血庫
    • 其他
  • 市場魅力度

第9章 市場分析與預測:各地區

  • 主要調查結果
  • 市場價值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力度

第10章 北美

第11章 歐洲

第12章 亞太地區

第13章 南美

第14章 中東·非洲

第15章 競爭環境

  • 競爭矩陣
  • 市場佔有率分析
  • 企業簡介
目錄

Syphilis Immunoassay Diagnostics Market - Scope of the Report

TMR'S report on the global syphilis immunoassay diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global syphilis immunoassay diagnostics market for the period of 2017 - 2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global syphilis immunoassay diagnostics market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involves bulk of the research efforts, wherein, analysts carry out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involves referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global syphilis immunoassay diagnostics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of the top-down and bottom-up approach to study various phenomena in the global syphilis immunoassay diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global syphilis immunoassay diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global syphilis immunoassay diagnostics market.

The report delves into the competitive landscape of the global syphilis immunoassay diagnostics market. Key players operating in the global syphilis immunoassay diagnostics market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of the players in the global syphilis immunoassay diagnostics market that have been profiled in this report.

Key Questions Answered in Syphilis Immunoassay Diagnostics Market Report

What is the sales/revenue expected to be generated by each product type across all regions during the forecast period?

What are the opportunities in the global syphilis immunoassay diagnostics market?

What are the major drivers, restraints, opportunities, and threats in the syphilis immunoassay diagnostics market?

Which region is likely to expand at the fastest CAGR during the forecast period?

Which syphilis immunoassay diagnostics and technology segments are expected to generate the highest revenue, globally, in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?

What was the market share or position of different companies operating in the global syphilis immunoassay diagnostics market in 2018?

Global Syphilis Immunoassay Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global syphilis immunoassay diagnostics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, technological advancement in different analyzers, syphilis disease prevalence & incident rate, number of syphilis tests done in the year 2018, cost of the test as per technology, and key mergers & acquisitions in the market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small sections. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Syphilis Immunoassay Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Class Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Technological Advancement
  • 5.2. Key Merger & Acquisition
  • 5.3. Top Three Players- Analysis
  • 5.4. Number of Syphilis Diagnostic Test, by Technology (2018)
  • 5.5. Pricing Analysis by Technology
  • 5.6. Disease Prevalence & Incidence Rate

6. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Product, 2017-2027

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2027
    • 6.3.1. Analyzers
    • 6.3.2. Kits & Reagents
  • 6.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Product

7. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Technology, 2017-2027

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
    • 7.3.1. ELISA
    • 7.3.2. CLIA
    • 7.3.3. Others
  • 7.4. Market Attractiveness, by Technology

8. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostics Labs
    • 8.3.3. Blood Banks
    • 8.3.4. Others
  • 8.4. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by End-user

9. Global Syphilis Immunoassay Diagnostics Market Analysis and Forecast, by Region, 2017-2027

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Syphilis Immunoassay Diagnostics Market Attractiveness, by Region

10. North America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
    • 10.2.1. Analyzers
    • 10.2.2. Kits & Reagents
  • 10.3. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
    • 10.3.1. ELISA
    • 10.3.2. CLIA
    • 10.3.3. Others
  • 10.4. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostics Labs
    • 10.4.3. Blood Banks
    • 10.4.4. Others
  • 10.5. North America Syphilis Immunoassay Diagnostics Market Value Forecast, by Country, 2017-2027
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Technology
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

  • 11.1. Introduction
    • 11.1.1. Key Finding
  • 11.2. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
    • 11.2.1. Analyzers
    • 11.2.2. Kits & Reagents
  • 11.3. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
    • 11.3.1. ELISA
    • 11.3.2. CLIA
    • 11.3.3. Others
  • 11.4. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Labs
    • 11.4.3. Blood Banks
    • 11.4.4. Others
  • 11.5. Europe Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Russia
    • 11.5.7. Turkey
    • 11.5.8. Eastern Europe
    • 11.5.9. Rest of Europe
  • 11.6. Europe Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Technology
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

  • 12.1. Introduction
    • 12.1.1. Key Finding
  • 12.2. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
    • 12.2.1. Analyzers
    • 12.2.2. Kits & Reagents
  • 12.3. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
    • 12.3.1. ELISA
    • 12.3.2. CLIA
    • 12.3.3. Others
  • 12.4. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Labs
    • 12.4.3. Blood Banks
    • 12.4.4. Others
  • 12.5. Asia Pacific Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. South Korea
    • 12.5.6. Vietnam
    • 12.5.7. Rest of Asia Pacific
  • 12.6. Asia Pacific Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Technology
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

  • 13.1. Introduction
    • 13.1.1. Key Finding
  • 13.2. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
    • 13.2.1. Analyzers
    • 13.2.2. Kits & Reagents
  • 13.3. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
    • 13.3.1. ELISA
    • 13.3.2. CLIA
    • 13.3.3. Others
  • 13.4. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Labs
    • 13.4.3. Blood Banks
    • 13.4.4. Others
  • 13.5. Latin America Syphilis Immunoassay Diagnostics Market Value Forecast by Country/Sub-region, 2017-2027
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Latin America Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Technology
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Syphilis Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

  • 14.1. Introduction
    • 14.1.1. Key Finding
  • 14.2. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027
    • 14.2.1. Analyzers
    • 14.2.2. Kits & Reagents
  • 14.3. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Technology, 2017-2027
    • 14.3.1. ELISA
    • 14.3.2. CLIA
    • 14.3.3. Others
  • 14.4. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Labs
    • 14.4.3. Blood Banks
    • 14.4.4. Others
  • 14.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Maghreb
    • 14.5.4. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Syphilis Immunoassay Diagnostics Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Technology
    • 14.6.3. By End-users
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis by Company (2018)
  • 15.3. Company Profiles
    • 15.3.1. F. Hoffmann-La Roche AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Company Financials
      • 15.3.1.3. Growth Strategies
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Bio-Rad Laboratories, Inc.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Company Financials
      • 15.3.2.3. Growth Strategies
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. BD
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Company Financials
      • 15.3.3.3. Growth Strategies
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Siemens Healthineers AG
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Company Financials
      • 15.3.4.3. Growth Strategies
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. DiaSorin S.p.A.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Company Financials
      • 15.3.5.3. Growth Strategies
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Abbott
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Company Financials
      • 15.3.6.3. Growth Strategies
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. Ortho Clinical Diagnostics (a part of Carlyle Group)
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Company Financials
      • 15.3.7.3. Growth Strategies
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Shenzhen New Industries Biomedical Engineering Co., Ltd.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Company Financials
      • 15.3.8.3. Growth Strategies
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. bioMerieux SA
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Company Financials
      • 15.3.9.3. Growth Strategies
      • 15.3.9.4. SWOT Analysis
    • 15.3.10. Fujirebio (Miraca Group) (Miraca Group)
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Company Financials
      • 15.3.10.3. Growth Strategies
      • 15.3.10.4. SWOT Analysis
    • 15.3.11. Fujirebio (Miraca Group)
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Company Financials
      • 15.3.11.3. Growth Strategies
      • 15.3.11.4. SWOT Analysis
    • 15.3.12. Danaher (Beckman Coulter, Inc.)
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Company Financials
      • 15.3.12.3. Growth Strategies
      • 15.3.12.4. SWOT Analysis

List of Tables

  • Table 01: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
  • Table 02: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
  • Table 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
  • Table 04: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017 - 2027
  • Table 05: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017 - 2027
  • Table 06: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
  • Table 07: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
  • Table 08: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
  • Table 09: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
  • Table 10: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
  • Table 11: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
  • Table 12: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
  • Table 13: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
  • Table 14: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
  • Table 15: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
  • Table 16: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
  • Table 17: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
  • Table 18: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
  • Table 19: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
  • Table 20: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017 - 2027
  • Table 21: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017 - 2027
  • Table 22: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017 - 2027
  • Table 23: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017 - 2027
  • Table 24: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast,

List of Figures

  • Figure 01: Global Syphilis Diagnostics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 02: Market Opportunity Map, by Product, 2018
  • Figure 03: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
  • Figure 04: Global Syphilis Diagnostics Market Value Share, by Product, 2018
  • Figure 05: Global Syphilis Diagnostics Market Value Share, by Technology, 2018
  • Figure 06: Global Syphilis Diagnostics Market Value Share, by End-user, 2018
  • Figure 07: Global Syphilis Diagnostics Market Value Share, by Region, 2018
  • Figure 08: Global Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 09: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Analyzers, 2017 - 2027
  • Figure 10: Global Syphilis Diagnostics Market Value (US$ Mn) Forecast, by Kits & Reagents, 2017 - 2027
  • Figure 11: Global Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
  • Figure 12: Global Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
  • Figure 13: Global Syphilis Diagnostics Market Value (US$ Mn), by ELISA Test, 2017 - 2027
  • Figure 14: Global Syphilis Diagnostics Market Value (US$ Mn), by CLIA Test, 2017 - 2027
  • Figure 15: Global Syphilis Diagnostics Market Value (US$ Mn), by Others, 2017 - 2027
  • Figure 16: Global Syphilis Diagnostics Market Attractiveness, by Technology, 2019 - 2027
  • Figure 17: Global Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 18: Global Syphilis Diagnostics Market Value (US$ Mn), by Hospitals, 2017 - 2027
  • Figure 19: Global Syphilis Diagnostics Market Value (US$ Mn), by Diagnostic Labs, 2017 - 2027
  • Figure 20: Global Syphilis Diagnostics Market Value (US$ Mn), by Blood Banks, 2017 - 2027
  • Figure 21: Global Syphilis Diagnostics Market Value (US$ Mn), by Others, 2017 - 2027
  • Figure 22: Global Syphilis Diagnostics Market Attractiveness, by End-user, 2019 - 2027
  • Figure 23: Global Syphilis Diagnostics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 24: Global Syphilis Diagnostics Market Attractiveness Analysis, by Region, 2019 - 2027
  • Figure 25: North America Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
  • Figure 26: North America Syphilis Diagnostics Market Attractiveness Analysis, by Country, 2019 - 2027
  • Figure 27: North America Syphilis Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 28: North America Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 29: North America Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
  • Figure 30: North America Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 31: North America Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
  • Figure 32: North America Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
  • Figure 33: North America Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
  • Figure 34: Europe Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
  • Figure 35: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
  • Figure 36: Europe Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 37: Europe Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 38: Europe Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
  • Figure 39: Europe Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 40: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
  • Figure 41: Europe Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
  • Figure 42: Europe Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
  • Figure 43: Asia Pacific Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
  • Figure 44: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
  • Figure 45: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 46: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 47: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
  • Figure 48: Asia Pacific Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 49: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
  • Figure 50: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
  • Figure 51: Asia Pacific Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
  • Figure 52: Latin America Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
  • Figure 53: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
  • Figure 54: Latin America Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 55: Latin America Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 56: Latin America Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
  • Figure 57: Latin America Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 58: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
  • Figure 59: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
  • Figure 60: Latin America Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
  • Figure 61: Middle East & Africa Syphilis Diagnostics Market Value (US$ Mn) Forecast, 2017 - 2027
  • Figure 62: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2019 - 2027
  • Figure 63: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 64: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 65: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by Technology, 2018 and 2027
  • Figure 66: Middle East & Africa Syphilis Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 67: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Product, 2019 - 2027
  • Figure 68: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by Technology, 2019 - 2027
  • Figure 69: Middle East & Africa Syphilis Diagnostics Market Attractiveness Analysis, by End-user, 2019 - 2027
  • Figure 70: Danaher Diagnostics Business Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 71: R&D Intensity (US$ Mn), Diagnostics Business Segment, 2015-2017
  • Figure 72: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Region, 2018
  • Figure 73: Breakdown of Net Sales (%), Danaher Diagnostics Business Segment, by Product, 2018
  • Figure 74: Becton, Dickinson. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 75: Becton, Dickinson. Breakdown of Net Sales (%), by Region/Country, 2018
  • Figure 76: Becton, Dickinson. Revenue Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 77: Becton, Dickinson. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2018
  • Figure 78: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 79: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 80: Breakdown of Net Sales (% Share), by Business Segment, 2018
  • Figure 81: Breakdown of Net Sales (% Share), by Region, 2018
  • Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 83: R&D Expenses (US$ Mn), 2015 - 2018
  • Figure 84: Breakdown of Net Sales (% Share), by Business Segment (2018)
  • Figure 85: Breakdown of Net Sales (% Share), by Region (2018)
  • Figure 86: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 87: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 88: Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 89: Breakdown of Net Sales (%), by Region/Country, 2018
  • Figure 90: DiaSorin S.p.A. Revenue (US$ Mn), 2015 - 2018
  • Figure 91: DiaSorin S.p.A. R&D Expenses (US$ Mn), 2015 - 2018
  • Figure 92: DiaSorin S.p.A. Sales and Marketing Expenses (US$ Mn, 2015 - 2018
  • Figure 93: DiaSorin S.p.A. Breakdown of Net Sales (%), by Region, 2018
  • Figure 94: DiaSorin S.p.A. Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 96: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 97: Breakdown of Net Sales (% Share), by Business Segment, 2018
  • Figure 98: Breakdown of Net Sales (% Share), by Region, 2018
  • Figure 99: Revenue (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 100: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 101: Breakdown of Net Sales (% Share), by Application, 2018
  • Figure 102: Breakdown of Net Sales (% Share), by Region, 2018
  • Figure 103: Miraca Group (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018
  • Figure 104: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015 - 2018